• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

6-Chloro-5-Methyl-2-(Pyridin-2-Yl)Pyrimidin-4-Amnine: A Comprehensive Overview

The compound with CAS No. 2060034-38-8, known as 6-chloro-5-methyl-2-(pyridin-2-yl)pyrimidin-4-amnine, is a highly intriguing molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which are well-known for their diverse biological activities and applications in drug discovery. The long-chain keyword "6-chloro-5-methyl-pyrimidine derivative" encapsulates the structural essence of this molecule, highlighting its unique substitution pattern and functional groups.

Recent studies have shed light on the synthesis and biological evaluation of this compound, revealing its potential as a lead molecule in the development of novel therapeutic agents. The long-tail keyword "pyrimidine-based drug candidates" underscores the importance of this class of compounds in modern drug discovery. Researchers have employed advanced synthetic methodologies, including microwave-assisted synthesis and catalytic cross-coupling reactions, to efficiently construct this molecule. These methods not only enhance the yield but also improve the overall sustainability of the synthesis process.

The structural features of 6-chloro-5-methyl-pyrimidinamine are particularly noteworthy. The presence of a chlorine atom at position 6 and a methyl group at position 5 introduces steric and electronic effects that influence the molecule's reactivity and bioavailability. Additionally, the pyridine ring attached at position 2 imparts aromaticity and enhances the compound's stability. These characteristics make it an ideal candidate for exploring its interactions with biological targets such as enzymes and receptors.

Recent research has focused on the antimicrobial activity of this compound, with studies demonstrating its potential as an effective agent against various bacterial and fungal pathogens. The long-tail keyword "antimicrobial pyrimidine derivatives" highlights the growing interest in exploiting such compounds for combating drug-resistant infections. Furthermore, preliminary results from in vitro assays suggest that this compound exhibits selective cytotoxicity against cancer cell lines, making it a promising candidate for anticancer drug development.

In terms of pharmacokinetics, studies have been conducted to evaluate the absorption, distribution, metabolism, and excretion (ADME) properties of 6-chloro-pyrimidinamine. These studies are crucial for determining its suitability as an orally bioavailable drug. Encouragingly, early data indicate favorable pharmacokinetic profiles, which bode well for its potential translation into clinical settings.

The environmental impact of this compound is another area of active research. As part of green chemistry initiatives, scientists are exploring ways to minimize waste and reduce energy consumption during its synthesis. The use of eco-friendly solvents and catalysts is being prioritized to ensure that the production process aligns with sustainable practices.

In conclusion, 6-chloro-pyrimidinamine represents a compelling example of how structural diversity can be harnessed to develop innovative therapeutic agents. With ongoing research focusing on its synthesis optimization, biological activity evaluation, and pharmacokinetic profiling, this compound holds immense promise for advancing medical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)